ST. LOUIS--(BUSINESS WIRE)--
Monsanto Company's (NYSE: MON) first technology developed specifically
for an international market, Intacta RR2 PROTM soybeans, has
received official approval from China's Ministry of Agriculture. With
this approval, Monsanto will now begin commercial preparation for the
full-scale launch of Intacta RR2 PROTM soybeans in Brazil for
the upcoming crop season.

Intacta RR2 PROTM soybeans are expected to become one of the
cornerstone products in Monsanto's next-generation soybean platform. The
technology represents one of the most significant growth drivers in its
global portfolio, and it is estimated that it could deliver benefits to
farmers in more than 100 million acres across South America.

"This approval represents a significant milestone for Brazilian farmers
and our company, and showcases the next wave of innovation that is
poised to drive the decade of the soybean at Monsanto," said Brett
Begemann, Monsanto's president and chief commercial officer.
"Importantly, the introduction of Intacta RR2 PROTM
brings a new choice in insect control and convenience to Brazilian
farmers, and creates the opportunity to expand our soybean platform as
we accelerate innovation in this core crop."

Along with Monsanto, multiple South American seed companies are
anticipated to launch Intacta RR2 PRO this coming season.

Final Ground Breakers® Results Set Tone for Commercial Opportunity

In conjunction with the transition to commercial preparation for the
upcoming season, Monsanto also unveiled the final results for its latest
year of Ground Breakers® on-farm trials in Brazil. This year, the
company doubled its Ground Breakers® program in Brazil to include 1,000
growers, and final results from this year's harvest demonstrate another
year of significant yield advantage of greater than four bushels per
acre against first-generation Roundup Ready® soybeans.

"The experience and insight we've gained from working with farmers
through two years of Ground Breakers® on-farm trials has us
well-positioned for a successful product launch," Begemann said.
"Intacta RR2 PROTM represents meaningful new value for
the farmer and significant business growth opportunity for Monsanto."

The company noted that the commercial launch in Brazil becomes the
catalyst for successive launches of Intacta RR2 PROTM
soybeans throughout South America, ultimately accessing a
100-million-acre total opportunity. Monsanto expects Ground Breakers®
trials for Intacta RR2 PRO in Argentina in fiscal year 2014, with a
commercial launch expected in fiscal 2015. Monsanto is currently
developing the second- and third-generation of Intacta RR2 PROTM
to provide additional benefits to growers in the region.

Intacta RR2 PRO soybeans offer three distinct benefits for growers:
increased yield potential; protection against major pests that attack
soybeans – velvetbean caterpillar, soybean looper, bean shoot borer,
bollworm, corn stalk borer and Helicoverpa; and tolerance to glyphosate
herbicide.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based
solutions and agricultural products that improve farm productivity and
food quality. Monsanto remains focused on enabling both small-holder and
large-scale farmers to produce more from their land while conserving
more of our world's natural resources such as water and energy. To learn
more about our business and our commitments, please visit: www.monsanto.com
. Follow our business on Twitter® at www.twitter.com/MonsantoCo,
on the company blog, Beyond the Rows® at www.monsantoblog.com,
or subscribe to our News
Release RSS Feed
.

Forward-Looking Statements:

Certain statements contained in this presentation are
"forward-looking statements," such as statements concerning the
company's anticipated financial results, current and future product
performance, regulatory approvals, business and financial plans and
other non-historical facts. These statements are based on current
expectations and currently available information. However, since these
statements are based on factors that involve risks and uncertainties,
the company's actual performance and results may differ materially from
those described or implied by such forward-looking statements. Factors
that could cause or contribute to such differences include, among
others: continued competition in seeds, traits and agricultural
chemicals; the company's exposure to various contingencies, including
those related to intellectual property protection, regulatory compliance
and the speed with which approvals are received, and public acceptance
of biotechnology products; the success of the company's research and
development activities; the outcomes of major lawsuits and the
previously announced SEC investigation; developments related to foreign
currencies and economies; successful operation of recent acquisitions;
fluctuations in commodity prices; compliance with regulations affecting
our manufacturing; the accuracy of the company's estimates related to
distribution inventory levels; the company's ability to fund its
short-term financing needs and to obtain payment for the products that
it sells; the effect of weather conditions, natural disasters and
accidents on the agriculture business or the company's facilities; and
other risks and factors detailed in the company's most recent periodic
report to the SEC. Undue reliance should not be placed on these
forward-looking statements, which are current only as of the date of
this presentation. The company disclaims any current intention or
obligation to update any forward-looking statements or any of the
factors that may affect actual results.